What does CUSIP 558868105 represent in this 13F holders report?

CUSIP 558868105 is the security identifier for MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in Q2 2021?

147 institutional investors reported MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock for Q2 2021. Use the holders table for investor-level position and value details.

MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)

CUSIP: 558868105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock
Shares outstanding: 22,766,960
Total 13F shares: 11,229,236
Share change: -981,208
Total reported value: $1,093,866,439
Put/Call ratio: 92%
Price per share: $97.41
Number of holders: 147
Value change: -$99,083,348
Number of buys: 87
Number of sells: 50

Quarterly Holders Quick Answers

What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 558868105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	8.3%	1,893,066	$221,432,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	6.6%	1,499,213	$175,363,000	—	31 Mar 2021	13F
Avoro Capital Advisors LLC	13F	Company	6.3%	1,425,000	$166,682,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	4.4%	997,809	$116,713,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	4.2%	956,096	$111,836,000	—	31 Mar 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.6%	816,834	$95,546,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	2.6%	585,750	$68,515,000	—	31 Mar 2021	13F
ARMISTICE CAPITAL, LLC	13F	Company	1.5%	350,000	$40,940,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	1.2%	262,894	$30,751,000	—	31 Mar 2021	13F
Rock Springs Capital Management LP	13F	Company	1.1%	258,500	$30,237,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.97%	219,805	$25,710,000	—	31 Mar 2021	13F
Artisan Partners Limited Partnership	13F	Company	0.94%	214,425	$25,081,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.79%	180,215	$21,080,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.78%	178,640	$20,896,000	—	31 Mar 2021	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.76%	172,511	$20,178,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.68%	154,796	$18,106,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.55%	124,176	$14,525,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.51%	115,840	$13,550,000	—	31 Mar 2021	13F
L1 Capital Pty Ltd	13F	Company	0.49%	112,604	$13,171,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.47%	106,566	$12,465,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.44%	100,578	$11,765,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.39%	88,846	$10,392,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.38%	85,541	$10,006,000	—	31 Mar 2021	13F
PFM Health Sciences, LP	13F	Company	0.36%	82,534	$9,654,000	—	31 Mar 2021	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.32%	72,342	$8,462,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.28%	64,359	$7,529,000	—	31 Mar 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.27%	62,323	$7,290,000	—	31 Mar 2021	13F
Tao Capital Management LP	13F	Company	0.23%	51,396	$6,012,000	—	31 Mar 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.17%	39,721	$4,646,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.16%	35,293	$4,128,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.15%	34,827	$4,074,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.15%	34,282	$4,010,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.15%	33,951	$3,971,000	—	31 Mar 2021	13F
Capital Impact Advisors, LLC	13F	Company	0.15%	33,048	$3,866,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.14%	31,641	$3,701,000	—	31 Mar 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.13%	30,454	$3,562,000	—	31 Mar 2021	13F
S.c.a. Candriam	13F	Individual	0.14%	31,722	$3,387,000	—	31 Mar 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.13%	28,751	$3,363,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.12%	28,275	$3,307,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.12%	27,979	$3,273,000	—	31 Mar 2021	13F
SG Americas Securities, LLC	13F	Company	0.12%	26,522	$3,102,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.1%	23,654	$2,768,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	23,294	$2,725,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.1%	23,000	$2,690,000	—	31 Mar 2021	13F
NATIXIS	13F	Company	0.1%	22,000	$2,573,000	—	31 Mar 2021	13F
Squarepoint Ops LLC	13F	Company	0.09%	19,464	$2,277,000	—	31 Mar 2021	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.08%	19,277	$2,255,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.08%	19,168	$2,242,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	17,900	$2,094,000	—	31 Mar 2021	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.07%	17,060	$1,996,000	—	31 Mar 2021	13F

Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2021

As of 30 Jun 2021, MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,229,236 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, ARMISTICE CAPITAL, LLC, Capital Research Global Investors, Rock Springs Capital Management LP, and Artisan Partners Limited Partnership. This page lists 147 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

135

Q2 2021 holders

147

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.